SUMMARY
INTRODUCTION
Hypocalcaemia is the usual accompaniment of. acute renal failure, excepting when renal faIlure has been caused by hypercalcaemia. Reports of hypercalcaemia in association with acute renal failure have been reviewed most recently by Patel and Ford (1976) and Turton and Leese (1977) . It usually occurs during the recovery period but, in a number of instances, the phases of hypercalcaemia and renal failure obviously overlapped.
This paper describes a series of patients, most of whom were hypercalcaemic whilst in renal failure.
Patients
Details of the sixteen patients are summarized in Table 1 .
The ages were between 23 and 74 with eight below the age of 32. Their acute renal failure was precipitated by a variety of conditionsaccidental trauma, surgical trauma, aspiration pneumonitis, peritonitis, generalized bacterial infection and viral illness. Two patients had documented pre-existing renal disease. Eleven patients were severely oliguric by the time they received their first haemodialysis. Three patients were in high output renal failure. Two patients did not receive haemodialysis. They were oliguric for 24 to 48 hours but were subsequently able to pass adequate urine volumes whilst remaining severely uraemic.
The periods between the initial insult and the first haemodialysis which they received (the morbid predialysis period) usually ranged from 4 to 20 days, although in one patient it was five weeks. The total documented course ranged between 15 and 127 days.
All patients showed a degree of pulmonary oedema at the time that haemodialysis was started, and all received intermittent positive pressure ventilation for a major part of their stay in the Intensive Care area. Some had proven episodes of septicemia acquired during the course of their treatment, and the majority had signs, at some time or other, of severe generalized infection which was not confirmed bacteriologically.
The patients received variable amounts of resuscitation fluid which was almost entirely as reconstituted freeze dried plasma or fresh frozen plasma.
Nine patients were fed intravenously for greater than 75% of their period in renal failure. Four were fed intravenously for less than 25 %. The intravenous feeding was based on infusions of 50% dextrose which aimed to provide at least 2,000 carbohydrate calories per day to accompany at least 10 g of aminoacid nitrogen per day. Insulin was added to the dextrose aiming to keep the blood sugar between 5 and 10 mmol/L. The carbohydrate calories were supplemented in some cases with intermittent infusions of 20% soya bean fat emulsion ("Intralipid") at the rate of 0.5 litres or less per day. The feeding by nasogastic tube used mainly electrolyte solution and No attempt was made to treat the hypercalcaemia when it occurred. As the patients were usually heavily sedated or recovering from heavy sedation, they did not complain of any symptoms of hypercalcaemia. A number of patients were noted to have conjunctival injection and five patients had tachycardia with short QT interval during their hypercalcaemic phase, suggesting that the ionic calcium was also high.
Five patients died in the Intensive Care area. One survivor required continuing haemodialysis. The rest recovered from the acute illness with normal blood urea and creatinine levels.
Methods of study
The disturbances in total calcium levels were the first to attract attention. They appeared as incidental observations during the patients' course of treatment. As a consequence of the inclusion of total calcium measurements in the routine biochemical screen (Kessler and Wolfman 1964) calcium levels were measured at least once per day when the machinery was operative.
Inorganic phosphate levels were not included in this screen and were measured at Total calories 7 500 nominal intervals of 3-4 days (Robinson, Roughan and Wagstaff 1971) .
Parathyroid hormone (PTH) levels were measurements of C-terminal immuno-reactive PTH (Addis on et al. 1971, Hesch, McIntosh and Woodhead 1975) , using antiserum As201. The measurements were made at nominal intervals of one week.
RESULTS

Calcium levels dllring acute renal failure
Twelve patients had documented hypocalcaemia for greater than 60% of their morbid predialysis period. Two patients had early calcium levels which did not fall below the lower end of the normal range. In two patients no early documentation was available. The calcium levels tended to rise from low or low normal values towards the upper end of the normal range. The time taken for this rise varied from 12 to 45 days from the initial insult.
All patients became hypercalcaemic at some time or other during their documented course of acute renal failure. In only one patient did the hypercalcaemic phase follow the phase of acute renal failure. In the others, the hypercalcaemic phase overlappe.d the phase of acute renal failure to an extent which increased in general with the duration of the acute renal failurc. If renal failure lasted longer than about 15 days, the later part of the phase of renal 4. 0 13434454354544658888967783335450556555334445.
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Recovery from hypercalcaemia followed recovery from renal failure with a lag of between 5 to 20 days. The initial insult and subsequent course was extremely varied. Figures 1 and 2 represent the course observed in two patients. The calcium phosphate and PTH axes are scaled and positioned in such a way that the normal ranges are superimposed, and the progress of the calcium, phosphate and PTH measurements may be followed simultaneously.
Phosphate changes
During the hypocalcaemia which usually marked the initial stages of the patient's course, phosphate levels could be high or normal. Elevated phosphate levels usually returned towards normal within a short time of the patient's entry into the intensive care area. This usually coincided with the period during which he was established on regular haemodialysis (daily or alternate daily) and during which his calorie input was elevated to at least 2,000 calories per day. From that time until the recovery of renal function, it seemed as though many of the major Anaesthesia and Intensive Care, Vol. VI, No. 4, November,1978 fluctuations III phosphate levels were reciprocally related to fluctuations in total calorie input. No worthwhile distinctions could be made as to whether the calories were supplied by the oral or intravenous route, or whether the non-nitrogenous calories were supplied as carbohydrate or fat.
Changes in phosphate levels were usually associated with reciprocal changes in calcium levels, but there were periods in most patients when calcium and phosphate levels rose concurrently. When PTH measurements were made at this time, they were usually high.
Changes in Parathyroid Hormone
Changes in PTH levels are plotted in Figure 3 , starting from the time of the initial insult.
Three patients with elevated PTH levels before six days were markedly hypocalcaemic at the time and the elevated PTH levels declined towards normal by 15 days. The one patient with normal PTH levels had normal total calcium levels.
Nine patients showed measured maximum levels of PTH between 15 and 45 days. Eight of these were hypercalcaemic at the time. In five of the nine patknts, the first pm le~ I was the highest recorded. Thus one could not say whether it was a secondary peak or simply a point on a slow decline from previously higher levels. However, in four of the nine patients, the peak was preceded by a measured rise in PTH levels. Of the five patients in whom PTH measurements were continued beyond 60 days, four showed a further (tertiary) peak at between 60 and 90 days.
Calcium, Phosphate and PTH interactions
The general pattern suggested by these cbservations was as follows. In the early stages, following the onset of the disease process, most of the patients had documented hypocalcaem;a and the documented PTH levels were high. At an intermediate stage between two and five weeks after the onset of the illness, high PTH levels seemed to be associated with high or rising calcium levels, and the usual reciprocal relationship between changes in calcium and phosphate levels sometimes disappeared. At periods later than ~:bout five weeks it became difficult to correlate rises and falls in calcium levels with rises and falls in PTH levels as they appeared to occur out of phase and at different frequencies.
DISCUSSION
Nell' features of the syndrome Some features of this series differ fro111 those previously reported.
Twenty-seven cases of hypercalcaemia in association with acute renal failure have been found in the literature. These come from a number of different hospitals over an eight year period. The sixteen cases in this report have been collected over eighteen months in a single hospital.
The patients in this series remained in renal fai!ure for longer pcriods (fifteen to eighty Anaesthesia and IllIensive Care, Vol. VI, No. 4, November, 1978 days) and the overlap between the period of hypercalcaemia and renal failure was accentuated. Although the onset of the period of hypercalcaemia was somewhat delayed in patients whose renal failure became more prolonged, it was not delayed sufficiently to prevent the overlap. In general, the recovery from the hypercalcaemic phase required recovery of the excretory capacity for urea and urine and followed it by some five to twenty days.
'PTH' measurements during longer periods of acute renal failure
The assay technique for measuring PTH depends on immunological recognition of the C terminal moiety of PTH. It does not distinguish between the active whole hormone or large inactive fragments. These C terminal moieties tend to accumulate in renal failure (Freitag et al. 1978) . Although this inevitably reduces the importance which can be attached to the PTH measurements in this study, the following observations may be made.
The PTH levels in these patients showed fluctuations whose amplitudes were considerably larger than the standard deviation (0.16 ng/ml) of the variations within and between assays. The C-terminal moieties are cleared by glomerular filtration (Freitag et al. 1978) . Thus if PTH fluctuations were entirely due to fluctuations in the clearance of C-terminal PTH-moieties, one would have to invoke fluctuations in glomerular filtration at times when the patients were completely anuric.
Most of the PTH measurements in this series were high in relation to the simultaneous total calcium level. This was consistent with the studies of Kokot and Kuska (1976) . The appearance of elevated hormone levels and blunted end organ responsiveness in renal failure was found to apply also to the glucose-insulin-HGH system. Although an initial rise in PTH in association with l'he initial hypocalcaemia was documented for only three of the sixteen patients in this series, the association between high PTH and low total calcium levels is consistent with previously published data on patients in renal failure lasting from 2-3 weeks (Kovithavongs, Becker and Ing 1972 , Massry et al. 1974 , Kokot and Kuska 1976 .
The PTH elevations at between three and eight weeks were in general associated with elevated calcium levels. If these elevations reflected the changes in active PTH, it appears that the normal feedback relationship of calcium levels on PTH release were no longer effective. The hypercalcaemia may have been caused by high PTH. Kovithavongs, Becker and Ing (1972) showed in one of their four patients, that after a week, PTH measurements increased with increasing total calcium levels although that patient did not become hypercalcaemic. The elevated PTH levels found in a proportion of the previously reported cases of "hypercalcaemia in association with recovery from acute renal failure" are consistent with the above cbservations except for the fact that recovery from acute renal failure appears not to be a necessary condition.
The dissociation at later stages between fluctuations in PTH levels and fluctuations in calcium levels may have resulted from further distortion of the normal gain and time relations between stimulus and response in the feedback loop between calcium and parathyroid hormone.
Acute changes in phosphate levels on calcium/ PTH interactions
Sudden changes in total calorie input to these patients were often associated with abrupt changes in phosphate levels, presumably related to the ratios in which calories and phosphate were presented to the site of metabolism. The changes in phosphate levels from this and other causes had interesting repercussions on total calcium levels.
Although Massry et al. (1974) have shown that the calcaemic effect of parathyroid hormone is reduced in renal failure irrespective of whether phosphate levels are high, normal or low, there were suggestions that the sudden reduction of elevated phosphate levels in the presence of elevated PTH levels, would allow an abrupt calcium rise from normal to high levels.
Explanations for the above phenomenon (A) Early hypocalcaemia
Although total calcium levels were depressed initially in most of these patients, phosphate levels were not necessarily elevated at the same time. Although all our patients had suffered major physiological insults before entering the Intensive Care Area the contribution of acute muscle breakdown was obvious in only a minority. Thus, although imoaired phosphate clearance and extracellular calcifications induced by phosphate release from damaged muscle may have contributed to the hypocalcaemia, these factors cannot explain the hypocalcaemia in all cases.
CB) Later hypercalcaemia
The later hypercalcaemic tendency requires one to consider the possible contributions of a number of factors.
Calcium input into the patient
Eleven of the sixteen patients were on intravenous feeding when they developed their hypercalcaemia. The solutions used for intravenous feeding contained no calcium. When feeding via the gastro-intestinal tract was introduced, "Aminaid" was generally the main ingredient. Hypercalcaemia was usually well developed before substances containing appreciable amounts of calcium and phosphate (milk and "Flexical") were administered in substantial amounts. The vitamin D which they received with their intravenous feeding would thus not have greatly influenced the amount of calcium absorbed from the gut although activated vitamin D would still have been required for the osteolytic effect of parathyroid hormone.
Patients were dialysed against calcium concentrations of 1.7 mEq/l. This is calculated to produce a positive calcium balance, but patients who were dialysed for acute renal failure outside the Intensive Care Area did not become hypercalcaemic although they employed the same staff, equipment and dialysate solutions. In the intensive care patients, the inward gradient of ionized calcium may have been accentuated during periods of hypotension whilst on dialysis, by the infusion of anything between 0.5 and 2 litres of citrated plasma solutions. Infused citrate loads are rapidly cleared within 10 to 15 minutes in the presence of normal hepatic and renal function, but both of these functions are suspect in intensive care patients.
Despite these considerations, changes in calcium or PTH levels did not bear any obvious relationship to the volumes of citrated plasma solutions which were infused during dialysis nor were the post-dialysis calcium measurements significantly different from the measurements at the start of the dialysis.
If one accepts excessive calcium intake whilst on dialysis as a major reason for the periods of hypercalcaemia which were observed, one has to seek different major reasons for the periods of hypercalcaemia which occurred after recovery from acute renal failure.
Total and ionic calcium.
It may be that citrate and other calcium binding agents may have reduced the proportion of ionic calcium in the total calcium measurements and prevented the normal interplay with the parathyroid glands. However, the short QT intervals observed in a number of patients during hypercalcaemic phase suggested that the ionic calcium was also high.
Even so, it may be that intermittent reductions in ionic calcium during periods of citrate infusion caused intermittent stimulation of the parathyroid glands, altLough in the presence of renal failure, the previously secreted PTH may not have been cleared.
The albumin concentrations were usually depressed and albumin binding could not be blamed for a discrepancy between total and ionic calcium.
Intravenous feeding
Although most of the patients in this series received intravenous feeding for a major part of their illness, hypercalcaemia occurred in patients who received little or no intravenous feeding and in patients in whom intravenous feeding had been discontinued well before the onset of hypercalcaemia.
Immobilization
The patients in this series were far more inert than most sick patients. The dosages of sedatives and relaxants were extraordinarily high. The documented tendency of calcium mobilization from bones must be accentuated in this situation and the dramatic wasting of muscles which follows the prolonged use of muscle relaxants may have supplied the component of muscle damage which has been so prominent in the previously reported cases of this syndrome.
The prolonged duration of renal failure
This was possibly the most striking feature in this series. Ten of the patients in this series were in acute renal failure for greater than 40 days. One died. One required continuing haemodialysis. The majority made a recovery of renal function which was complete as far as could be judged by urea and creatinine levels and urinary sediment.
It may be that this prolonged phase of renal failure reflects the selection of patients and the severity of the initial and continuing illness which resulted in their admission to an Intensive Care Area. If so, a comparable series should appear, in due course, from centres which deal with this type of patient.
Other considerations
No measurements were made of magnesium levels, or thyrocalcitonin levels, and no useful consideration can be given to these influences on the basis of results in this series.
Changes in calcaemic response to PTH
It would be satisfying to invoke a single major explanation for the phenomena seen in these and previously reported patients rather than to select necessarily different major explanations appropriate to the different circumstances pertaining to each individual case.
An alteration in the metabolism of vitamin D was suggested by the case reported by Chertow, Plymale and Becker (1974) and has been pursued in the experimental work of Massry and associates (1973 Massry and associates ( , 1974 Massry and associates ( , 1976 . This mechanism is consistent with the major observations in all cases and can accommodate modifications to include any of the factors discussed above. It does not require any firm statements as to the behaviour of PTH levels.
In uremic situations there is a resistance to the calcaemic action of PTH. This may be at least partly due to an impairment of the second hydroxylation of vitamin D by damaged kidneys. This would explain the finding of early hypocalcaemia and high PTH levels which characterizes the early phase of acute renal failure.
The hypercalcaemic phase, whether or not it occurs in association with the recovery of the renal output mechanisms for urea and urine, may be explained in terms of recovery with rebound of the sensitivity of bone to the calcaemic action of normal or elevated levels of PTH. This may be due to the recovery of the renal capacity to activate vitamin D.
